Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Change in Account Payables (2021 - 2025)

Prime Medicine filings provide 5 years of Change in Account Payables readings, the most recent being -$581000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 123.62% to -$581000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $996000.0, a 118.95% increase, with the full-year FY2025 number at $996000.0, up 118.95% from a year prior.
  • Change in Account Payables hit -$581000.0 in Q4 2025 for Prime Medicine, down from $3.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $5.8 million in Q3 2023 to a low of -$5.9 million in Q1 2024.
  • Median Change in Account Payables over the past 5 years was $1.0 million (2022), compared with a mean of $436294.1.
  • Biggest five-year swings in Change in Account Payables: soared 1535.66% in 2023 and later plummeted 1066.67% in 2024.
  • Prime Medicine's Change in Account Payables stood at $80000.0 in 2021, then surged by 438.75% to $431000.0 in 2022, then surged by 428.77% to $2.3 million in 2023, then grew by 7.94% to $2.5 million in 2024, then plummeted by 123.62% to -$581000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$581000.0 (Q4 2025), $3.0 million (Q3 2025), and -$3.3 million (Q2 2025) per Business Quant data.